Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Iovance Biotherapeutics (IOVA) Shares Issued (2016 - 2025)

Historic Shares Issued for Iovance Biotherapeutics (IOVA) over the last 11 years, with Q3 2025 value amounting to $88.5 million.

  • Iovance Biotherapeutics' Shares Issued rose 8628.73% to $88.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.5 million, marking a year-over-year decrease of 3694.29%. This contributed to the annual value of $397.3 million for FY2024, which is 1424.12% down from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Shares Issued stood at $88.5 million, which was up 8628.73% from $13.1 million recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Shares Issued ranged from a high of $260.1 million in Q1 2023 and a low of $1000.0 during Q4 2023
  • For the 3-year period, Iovance Biotherapeutics' Shares Issued averaged around $123.5 million, with its median value being $148.9 million (2025).
  • The largest annual percentage gain for Iovance Biotherapeutics' Shares Issued in the last 5 years was 8628.73% (2025), contrasted with its biggest fall of 9139.74% (2025).
  • Iovance Biotherapeutics' Shares Issued (Quarter) stood at $1000.0 in 2023, then skyrocketed by 4751700.0% to $47.5 million in 2024, then surged by 86.29% to $88.5 million in 2025.
  • Its Shares Issued was $88.5 million in Q3 2025, compared to $13.1 million in Q2 2025 and $148.9 million in Q1 2025.